INTRAHOSPITAL MORTALITY OF PATIENTS SUFFERING AN ACUTE MYOCARDIAL INFARCTION AND THE IMPORTANCE OF MYOCARDIAL REINFARCTION IN THE INTRAHOSPITAL PERIOD

Z. Marčetić ,
Z. Marčetić

Internal clinic, Medical faculty Pristina , Kosovska Mitrovica , Kosovo*

S. Sovtić ,
S. Sovtić

Internal clinic, Medical faculty Pristina , Kosovska Mitrovica , Kosovo*

Z. Stašević ,
Z. Stašević

CHC Pristina - Gracanica Bosnia and Herzegovina

T. Novaković ,
T. Novaković

Internal clinic, Medical faculty Pristina , Kosovska Mitrovica , Kosovo*

D. Đikić ,
D. Đikić

CHC Pristina - Gracanica Bosnia and Herzegovina

S. Vasić ,
S. Vasić

CHC Pristina - Gracanica Bosnia and Herzegovina

G. Antić ,
G. Antić

CHC Pristina - Gracanica Bosnia and Herzegovina

D. Rašić ,
D. Rašić

Internal clinic, Medical faculty Pristina , Kosovska Mitrovica , Kosovo*

S. Lazić ,
S. Lazić

Internal clinic, Medical faculty Pristina , Kosovska Mitrovica , Kosovo*

M. Šipić ,
M. Šipić

Internal clinic, Medical faculty Pristina , Kosovska Mitrovica , Kosovo*

V. Perić
V. Perić

Internal clinic, Medical faculty Pristina , Kosovska Mitrovica , Kosovo*

Published: 01.12.2008.

Volume 36, Issue 2 (2008)

pp. 17-23;

https://doi.org/10.70949/pramed200802243M

Abstract

Conclusion about efficacious of some medication can be given based on reducing morbidity and mortality in patients treated with that medication.. Aim of this work was to estimate intrahospital mortality in patients with acute myocardial infarction (AMI), role of myocardial reinfarction in that and side effects of medications in patients who were different treated in initial phase of AMI, based on what they were separated in three different therapeutic groups: group treated with thrombolytic therapy, group treated with beta-blockers and group treated with nitrates. It was shown that intrahospital mortality is highest in patients treated with nitrates but there was not significant difference between thera-peutic groups in frequency of myocardial reinfarction while frequency of complications and side effects were in range as in others similar studies.

Keywords

References

1.
Gruppo Italiano per lo Studio della Streptochinasi nell Infarcto Miocardico (GISSI). Long-term effects of intravenous thrombolysis in acute myocardial infarction: final report of the GISSI study. Lancet. 2:871–4.
2.
H. CJ, G. K, R. R. Thrombolysis in myocardial infarction (TIMI) trial, Phase I: A comparison between intravenous plasminogen activator and intravenous streptokinase. Circulation. 76:142–54.
3.
The ISAM Study Group: A prospective trial of intravenous streptokinase in acute myocardial infarction. N Engl J Med. 314:1465–71.
4.
W. KJ, L. RJ, B. DK, L. SM, C. M, K FJ. The Western Washington myocardial infarction, A-12 month follow-up report. N Engl J Med. 312:1073–8.
5.
sar JG. Analiza intrahospitalnog mortaliteta u bolesnika sa akutnim infarktom miokarda lečenih intravenskom streptokinazom. U zborniku radova II kongresa kardiologa Srbije. 17. (Suppl. 1.

Citation

Copyright

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Indexed by